相似文献
1
C-reactive protein in childhood dermatomyositis.
Ann Rheum Dis. 1982 Oct;41(5):483-5. doi: 10.1136/ard.41.5.483.
2
Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis.
Arthritis Res Ther. 2013 Sep 23;15(5):R131. doi: 10.1186/ar4311.
3
[Levels of acute-phase-reactants in patient with dermatomysitis and its correlations with IL-6 and dermatomyositis disease activity].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;44(5):814-7.
4
Correlation of serum neopterin concentrations with disease activity in juvenile dermatomyositis.
Arch Dis Child. 1993 Aug;69(2):232-5. doi: 10.1136/adc.69.2.232.
5
Increased Soluble Cytoplasmic Bcl-2 Protein Serum Levels and Expression and Decreased Fas Expression in Lymphocytes and Monocytes in Juvenile Dermatomyositis.
J Rheumatol. 2018 Nov;45(11):1577-1580. doi: 10.3899/jrheum.171248. Epub 2018 Aug 1.
6
Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Arthritis Rheum. 1994 Dec;37(12):1744-51. doi: 10.1002/art.1780371206.
7
Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies.
Clin Exp Rheumatol. 2015 May-Jun;33(3):399-404. Epub 2015 May 1.
8
Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis.
Chin Med J (Engl). 2017 Sep 5;130(17):2101-2106. doi: 10.4103/0366-6999.213419.
9
Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Neuropathol Appl Neurobiol. 2019 Jun;45(4):410-420. doi: 10.1111/nan.12498. Epub 2018 Jun 4.
10
Diagnostic significance of membrane attack complex and vitronectin in childhood dermatomyositis.
J Child Neurol. 2005 Jul;20(7):597-602. doi: 10.1177/08830738050200071201.
引用本文的文献
1
C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.
Diseases. 2023 Sep 28;11(4):132. doi: 10.3390/diseases11040132.
2
Use of C-Reactive Protein and Ferritin Biomarkers in Daily Pediatric Practice.
Pediatr Rev. 2020 Apr;41(4):172-183. doi: 10.1542/pir.2018-0101.
3
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Front Immunol. 2018 Dec 18;9:2951. doi: 10.3389/fimmu.2018.02951. eCollection 2018.
4
Laboratory evaluation of the inflammatory myopathies.
Clin Diagn Lab Immunol. 1995 Jan;2(1):1-9. doi: 10.1128/cdli.2.1.1-9.1995.
5
Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis.
Thorax. 1987 May;42(5):332-5. doi: 10.1136/thx.42.5.332.
本文引用的文献
1
C-reactive protein in the chronic rheumatic diseases.
Lancet. 1951 Nov 3;2(6688):807-11. doi: 10.1016/s0140-6736(51)91595-4.
2
C-reactive protein levels in systemic lupus erythematosus: a classification criterion?
Arthritis Rheum. 1980 Jun;23(6):770-1. doi: 10.1002/art.1780230609.
3
C-reactive protein in the differential diagnosis between infection and disease reactivation in SLE.
J Rheumatol. 1981 Mar-Apr;8(2):291-4.
4
C-reactive protein fifty years on.
Lancet. 1981 Mar 21;1(8221):653-7. doi: 10.1016/s0140-6736(81)91565-8.
5
Measurements of muscle strength and performance in children with normal and diseased muscle.
Arch Dis Child. 1976 Dec;51(12):957-63. doi: 10.1136/adc.51.12.957.
6
C-reactive protein in systemic lupus erythematosus.
Arthritis Rheum. 1977 Jun;20(5):1065-70. doi: 10.1002/art.1780200505.
7
Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes.
Br Med J. 1977 Jan 22;1(6055):195-7. doi: 10.1136/bmj.1.6055.195.
8
Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.
Clin Exp Immunol. 1978 Apr;32(1):119-24.
9
Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus.
Arthritis Rheum. 1979 Jan;22(1):7-12. doi: 10.1002/art.1780220102.
Zotero 插件